Literature DB >> 22566260

Left upper lobectomy with combined resection of the distal arch aorta after chemoradiotherapy for locally advanced lung cancer.

Toshiki Tanaka1, Kazuhiro Ueda, Masataro Hayashi, Akihito Mikamo, Nobuyuki Tanaka, Kimikazu Hamano.   

Abstract

We report a case of complete resection of lung cancer involving the thoracic aorta, after induction chemoradiotherapy in a 55-year-old man. The chemoradiotherapy, which consisted of two courses of platinum-based chemotherapy with concurrent radiation to a total of 40 Gy, resulted in a partial response. Left upper lobectomy with combined resection and reconstruction of the distal arch aorta and left subclavian artery was performed under cardiopulmonary bypass. The patient was given two courses of platinum-based adjuvant chemotherapy, and there has been no sign of recurrence in the 34 months since his operation.

Entities:  

Mesh:

Year:  2012        PMID: 22566260     DOI: 10.1007/s11748-012-0005-7

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  12 in total

1.  Effects of coronary artery bypass grafting on cellular immunity with or without cardiopulmonary bypass: changes in lymphocytes subsets.

Authors:  Haluk Akbas; A Cenk Erdal; Emel Demiralp; Mete Alp
Journal:  Cardiovasc Surg       Date:  2002-12

2.  Effect of cardiopulmonary bypass on cancer prognosis.

Authors:  Shuichi Suzuki; Akihiko Usui; Katsuhiko Yoshida; Akio Matsuura; Toshihiko Ichihara; Yuichi Ueda
Journal:  Asian Cardiovasc Thorac Ann       Date:  2010-12

3.  Value of 18F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small-cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy.

Authors:  Christoph Pöttgen; Sabine Levegrün; Dirk Theegarten; Simone Marnitz; Sara Grehl; Roman Pink; Wilfried Eberhardt; Georgios Stamatis; Thomas Gauler; Gerald Antoch; Andreas Bockisch; Martin Stuschke
Journal:  Clin Cancer Res       Date:  2006-01-01       Impact factor: 12.531

Review 4.  Multimodality therapy for stage III non-small-cell lung cancer.

Authors:  Daniel Farray; Nena Mirkovic; Kathy S Albain
Journal:  J Clin Oncol       Date:  2005-05-10       Impact factor: 44.544

5.  Surgical management of lung cancer invading the aorta or the superior vena cava.

Authors:  P Misthos; G Papagiannakis; J Kokotsakis; G Lazopoulos; E Skouteli; A Lioulias
Journal:  Lung Cancer       Date:  2007-01-16       Impact factor: 5.705

6.  The influence of open-heart surgery on survival of patients with co-existent surgically amenable lung cancer (stages I and II).

Authors:  A J Voets; K S Joesoef; M E van Teeffelen
Journal:  Eur J Cardiothorac Surg       Date:  1997-12       Impact factor: 4.191

7.  Surgical resection for lung cancer with infiltration of the thoracic aorta.

Authors:  Mitsunori Ohta; Hirohisa Hirabayasi; Hiroyuki Shiono; Masato Minami; Hajime Maeda; Hiroshi Takano; Shinichiro Miyoshi; Hikaru Matsuda
Journal:  J Thorac Cardiovasc Surg       Date:  2005-04       Impact factor: 5.209

8.  Synergistic immunosuppression caused by high-dose methylprednisolone and cardiopulmonary bypass.

Authors:  H Mayumi; Q W Zhang; A Nakashima; M Masuda; H Kohno; Y Kawachi; H Yasui
Journal:  Ann Thorac Surg       Date:  1997-01       Impact factor: 4.330

9.  Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival.

Authors:  Robert James Cerfolio; Ayesha S Bryant; Virginia L Jones; Robert Michael Cerfolio
Journal:  Eur J Cardiothorac Surg       Date:  2009-02-23       Impact factor: 4.191

10.  Extended resection of the left atrium, great vessels, or both for lung cancer.

Authors:  R Tsuchiya; H Asamura; H Kondo; T Goya; T Naruke
Journal:  Ann Thorac Surg       Date:  1994-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.